Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Compounds combining PAF antagonist and 5-ASA claimed by Uriach for IBD

April 29, 1997

Novopharm and Glaxo Wellcome reach agreement for ranitidine

April 28, 1997

ImmuCell's TravelGAM to enter field study in cooperation with U.S. Navy

April 24, 1997

DA-9601 shows promise for IBD

April 23, 1997

Isis Pharmaceuticals initiates phase III trials of its antisense drug for Crohn's disease

April 22, 1997

Cholecystokinin antagonists for pancreatic disorders described by Tanabe

April 18, 1997

New antiulcer agents from Fujisawa

April 17, 1997

Eisai/Janssen form strategic alliance for rabeprazole

April 17, 1997

Antiulcer activity of cromakalim

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...